Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Pemphigus in Young Patients With Thymic Anomalies. | Front Med (Lausanne) | 2022 | 35280858 | PubTator, text mining | PubMed |
| Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review. | Pathol Res Pract | 2022 | 35278817 | PubTator, text mining | PubMed |
| Universality of stretching separation. | J Fluid Mech | 2022 | 35273406 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Grainyhead-like (Grhl) Target Genes in Development and Cancer. | Int J Mol Sci | 2022 | 35269877 | PubTator, text mining | PubMed |
| In Vitro Disease Models for Understanding Psoriasis and Atopic Dermatitis. | Front Bioeng Biotechnol | 2022 | 35265594 | PubTator, text mining | PubMed |
| The impact of the genetic background in a patient with papillary thyroid cancer and familial adenomatous polyposis. | Arch Endocrinol Metab | 2022 | 35263052 | PubTator, text mining | PubMed |
| Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells. | Elife | 2022 | 35257663 | PubTator, text mining | PubMed |
| The positive impact of rituximab on the quality of life and mental health in patients with pemphigus. | JAAD Int | 2022 | 35252887 | PubTator, text mining | PubMed |
| Diagnosis and Treatment Challenges of an Atypical Case of Pemphigus vulgaris During the COVID-19 Pandemic. | Cureus | 2022 | 35251811 | PubTator, text mining | PubMed |
| Characterization of Desmoglein 3 (DSG3) as a Sensitive and Specific Marker for Esophageal Squamous Cell Carcinoma. | Gastroenterol Res Pract | 2022 | 35251162 | PubTator, text mining | PubMed |
| Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions. | J Asthma Allergy | 2022 | 35250281 | PubTator, text mining | PubMed |
| FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation. | J Exp Clin Cancer Res | 2022 | 35241148 | PubTator, text mining | PubMed |
| Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges. | Hum Vaccin Immunother | 2022 | 35240914 | PubTator, text mining | PubMed |
| Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma. | J Eur Acad Dermatol Venereol | 2022 | 35238435 | PubTator, text mining | PubMed |
| Effect of 2D and 3D Culture Microenvironments on Mesenchymal Stem Cell-Derived Extracellular Vesicles Potencies. | Front Cell Dev Biol | 2022 | 35237601 | PubTator, text mining | PubMed |
| Digital synthesis of free-form multimaterial structures for realization of arbitrary programmed mechanical responses. | Proc Natl Acad Sci U S A | 2022 | 35235446 | PubTator, text mining | PubMed |
| Pemphigus Vulgaris: Present and Future Therapeutic Strategies. | Dermatol Pract Concept | 2022 | 35223181 | PubTator, text mining | PubMed |
| A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis. | Front Immunol | 2022 | 35222408 | PubTator, text mining | PubMed |
| Localized Blistering Eruption of the Face and Neck - A Case Study and Differential Considerations. | Clin Cosmet Investig Dermatol | 2022 | 35221704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=40